4//SEC Filing
Janku Filip 4
Accession 0001209191-22-061947
CIK 0001826457other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:42 PM ET
Size
5.7 KB
Accession
0001209191-22-061947
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-15+36,000→ 36,000 totalExercise: $7.56Exp: 2032-10-02→ Common Stock (36,000 underlying)
Footnotes (2)
- [F1]On October 3, 2022, the Reporting Person was granted an option to purchase 36,000 shares of Common Stock, subject to the satisfaction of certain performance criteria. On December 15, 2022, the performance criteria underlying such shares were met.
- [F2]The shares underlying this option shall vest in full on June 15, 2024, subject to the Reporting Person's continued service on such date.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001862930
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:42 PM ET
- Size
- 5.7 KB